Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 672 entries
View as:

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Phase: N/A Priority: Normal
NCT ID: NCT06333808 Org: User:
Start: 03/25/24 End: 12/31/29 Due: 12/31/30

Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

Phase: N/A Priority: Normal
NCT ID: NCT06544733 Org: User:
Start: 08/20/24 End: 06/30/29 Due: 06/30/30

Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02885181 Org: User:
Start: 09/21/16 End: 09/20/17 Due: 09/20/18

PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT00362544 Org: User:
Start: 10/31/03 End: 03/31/06 Due: 03/31/07

Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03248479 Org: User:
Start: 09/08/17 End: 09/05/23 Due: 09/05/24

Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01479465 Org: User:
Start: 12/31/11 End: 02/28/15 Due: 02/28/16

Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002234 Org: User:
Start: - End: - Due: -

Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT03207815 Org: User:
Start: 07/26/17 End: 04/22/21 Due: 04/22/22

Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout

Phase: N/A Priority: Normal
NCT ID: NCT02252835 Org: User:
Start: 08/31/14 End: 12/31/14 Due: 12/31/15

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

Phase: N/A Priority: Normal
NCT ID: NCT05502341 Org: User:
Start: 08/16/22 End: 07/31/28 Due: 07/31/29

Gilead Sustained Virologic Response (SVR) Registry

Phase: N/A Priority: Normal
NCT ID: NCT01457755 Org: User:
Start: 04/13/12 End: 01/08/18 Due: 01/08/19

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT03739866 Org: User:
Start: 11/26/18 End: 06/15/20 Due: 06/15/21

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02120300 Org: User:
Start: 04/30/14 End: 08/31/15 Due: 08/31/16

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Phase: N/A Priority: Normal
NCT ID: NCT01442038 Org: User:
Start: 10/31/11 End: 02/28/15 Due: 02/28/16

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Phase: N/A Priority: Normal
NCT ID: NCT01425359 Org: User:
Start: 09/30/11 End: 10/31/12 Due: 10/31/13

Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)

Phase: N/A Priority: Normal
NCT ID: NCT01797419 Org: User:
Start: 05/31/13 End: 08/31/13 Due: 08/31/14

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Phase: N/A Priority: Normal
NCT ID: NCT03602560 Org: User:
Start: 10/01/18 End: 02/16/20 Due: 02/16/21

Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT05765344 Org: User:
Start: 03/15/23 End: 01/13/25 Due: 01/13/26

COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis

Phase: N/A Priority: Normal
NCT ID: NCT00334412 Org: User:
Start: 03/31/04 End: 05/31/06 Due: 05/31/07

A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine

Phase: N/A Priority: Normal
NCT ID: NCT01675973 Org: User:
Start: 07/31/12 End: 08/31/12 Due: 08/31/13

Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05089734 Org: User:
Start: 11/17/21 End: 01/31/26 Due: 01/31/27

Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01472185 Org: User:
Start: 11/30/11 End: 10/31/13 Due: 10/31/14

A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)

Phase: N/A Priority: Normal
NCT ID: NCT00507507 Org: User:
Start: 09/30/07 End: 08/31/12 Due: 08/31/13

Study of Sacituzumab Govitecan in Patients With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT05119907 Org: User:
Start: 10/12/21 End: 12/31/25 Due: 12/31/26

Study of Remdesivir in Participants Below 18 Years Old With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04431453 Org: User:
Start: 07/21/20 End: 02/10/23 Due: 02/10/24